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ABSTRACT
Iron is an important trace element for proper cell functioning. It is present in cytochromes, hemoglobin 
and myoglobin (Mb), where it binds to oxygen. It is also an electron acceptor in the respiratory chain. Mb 
is an 18 kDa heme-protein, highly expressed in skeletal muscle and heart. The expression of several genes 
involved in the metabolism of iron is post-transcriptionally regulated by this element. Iron was shown to 
interfere with the polyadenylation step, modifying their poly (A) tail length and, as a consequence, their 
stability and translation rate. The aim of this study was to investigate whether iron supplementation or 
long and short-term restriction affects Mb gene and protein expression, as well as Mb mRNA poly(A) 
tail length, in cardiac and skeletal muscles of rats. Long-term iron restriction caused an increase in Mb 
gene and protein expression in Soleus muscle. No changes were observed in extensor digitorum longus 
muscle and heart. Short-term iron supplementation after iron deprivation did not alter Mb gene expression 
and mRNA poly(A) tail length in all tissues studied. These results indicate that Mb gene and protein 
expression is upregulated in response to iron deprivation, an effect that is tissue-specific and seems to occur 
at transcriptional level.
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INTRODUCTION
Iron is a trace element that accepts and donates 
electrons. This property makes it extremely useful 
in several important reactions that are necessary for 
the appropriate functioning of the whole body. It is 
present in cytochromes, hemoglobin (Hb) which 
binds and transports O2 to tissues, myoglobin 
(Mb), which functions as a storage of O2 in cardiac 
and skeletal muscles, where it also delivers O2 to 
mitochondria, and in a wide variety of enzymes 
(Anderson et al. 2007, Andrews 2000, Li and 
Stocker 2009, Conrad and Umbreit 2000, Núñez 
et al. 2012). 
Iron deficiency is still a major nutritional 
problem today, affecting about 15% of people in the 
world. It is one of the causes of anemia, a disease 
that causes disability in thermoregulation during 
cold exposure, in psychomotor development and 
affects work capacity, among others, effects that 
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have been shown, both in humans and experimental 
animals (Beard et al. 1998, Gera and Sachdev 2002, 
Hass and Brownlie 2001, He et al. 2008, Hegde et 
al. 2006, Moy and Early 1999, Paiva et al. 2000, 
Zimmermann et al. 2005, Ebner and von Haehling 
2013).
Iron is acquired in diet, through animal foods 
(heme) and vegetables. The process of regulation 
of intestinal absorption of iron by enterocytes 
has fundamental importance for iron homeostasis 
and maintenance. Iron absorption is very well 
controlled by mechanisms that are triggered in 
response to iron content of diet and stock of iron in 
the body (Andrews 2000), thus preventing excess 
and deficiency of iron (Anderson et al. 2009). Iron 
homeostasis is very important and it is shown during 
intense exercise in which the level of iron decreases 
significantly right after it and the parameters of 
blood cells do not change (Skarpanska-Stejnborn et 
al. 2015). There are several proteins involved in the 
homeostasis of iron, which participates in a number 
of steps from its absorption to its storage. Increase 
and decrease of cellular iron content can regulate 
the expression of mRNAs and proteins responsible 
for its homeostasis. The regulation of expression 
of some genes responsible for iron metabolism 
occurs at post-transcriptional level and involves the 
untranslated regions of mRNAs that they encode, 
resulting in alterations in their stability and, as 
a consequence, in expression of related proteins 
(Butt et al. 1996, Hentze and Kühn 1996).
Surprisingly, skeletal muscle, which 
corresponds to about 40% of body weight and 
contains 10 to 15% of iron from the body (present 
in the heme portion of Mb and cytochrome c) has 
received little attention about their involvement in 
metabolism of iron, which is a key component of 
recognized roles that Mb and cytochromes play in 
the processes of storage, transport and use of O2 
(Robach et al. 2007, 2009).
Mb is a heme-protein of 18 kDa, highly 
expressed in skeletal muscle (especially in slow-
twitch, oxidative) and heart, and belongs to the same 
family of Hb (Hass and Brownlie 2001, Ordway 
and Garry 2004, Shikama 2005). Mb is localized 
at myocytes near to contractile proteins, acting as a 
protective molecule (Sher et al. 2014). It is believed 
that iron and/or heme participates meaningfully in 
transcriptional and/or post-transcriptional control 
of the expression of genes related to proteins that 
carry out functions related to it, which, directly or 
indirectly assist in the maintenance of homeostasis. 
Thus, based on (a) the high expression of 
Mb, which is essential for the maintenance of 
intracellular O2 storage and transportation to the 
mitochondria, (b) the role of Mb as an acceptor of 
reactive O2 and N2 species and (c) that about 15% 
of iron in the body is in part stored in Mb, this 
study aimed at investigating whether alterations 
in iron supply could affect Mb gene expression, 
which would place the iron as an important element 
involved in the regulation of the expression of this 
protein.
MATERIALS AND METHODS
ANIMALS AND TREATMENTS
Male Wistar rats (Rattus norvergicus) weighting 
approximately 250 g were obtained from Institute 
of Biomedical Sciences, University of São Paulo. 
They were housed in collective cages (5 animals 
per cage) in a room kept at constant temperature 
(23 ± 1°C) and on a 12-hour-light/12-hour-dark 
schedule, and subjected to long or short-term iron 
treatment, as follows. Long Term Treatment: 
Animals were divided into: I. Control group, in 
which animals were kept with food and water ad 
libitum. II. Iron Supplementation Group: in which 
animals were treated with ferrous sulfate (40 mg/
kg/day) in drinking water and food ad libitum 
(changed every each day). III. Iron Restriction 
group: animals kept in collective cages treated 
with an iron chelating agent, tannic acid (0.5 g/100 
ml) in drinking water (Onodera et al. 1994) and 
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fed ad libitum. After thirty days these animals 
were anaesthetized (Sodium Thiopental, 9 mg/100 
g) and euthanized by decapitation. Blood was 
collected from the trunk, for analysis of different 
hematimetric parameters: hematocrit, red blood 
cell count, mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), 
Hb and serum iron concentration. Short Term 
Treatment: Initially, animals were divided into 
two groups: I. Control group: animals kept in 
collective cages with food and water ad libitum. II. 
Iron Restriction group: animals kept in collective 
cages treated with tannic acid (0.5 g/100 ml) in 
drinking water (Onodera et al. 1994) and fed ad 
libitum for 30 d. After this period, animals treated 
with tannic acid were divided in two subgroups: 
(a) Iron restriction, and (b) Acute iron treatment, 
in which the animals received intraperitoneal (ip) 
iron saccharate hydroxide solution (6 mg/100 g 
body weight - NYCOMED) and were euthanized 
by decapitation after 30 min, 1 h, 2 h, 12 h and 
24 h. Blood was collected for analysis of serum 
iron concentration. After the specific periods of 
treatments Soleus (slow oxidative), Extensor 
Digitorum Longus (EDL, fast glycolytic) and heart 
(LV, left ventricle) muscles were removed and 
subjected to: (a) Total RNA extraction to assess 
Mb mRNA content and poly(A) tail length and, (b) 
Total protein extraction and specific fractionation 
to obtain cytosolic fraction, in order to evaluate Mb 
protein content.
The experimental protocol conformed with the 
ethical principles in animal research adopted by 
the Brazilian College of Animal Experimentation 
and was approved by the Institute of Biomedical 
Sciences/University of São Paulo-Ethical 
Committee for Animal Research (no. 94/2007).
PROCEDURES
Northern blot analysis. Total RNA was isolated 
using the acid guanidinium thiocyanate-phenol-
chloroform extraction method and quantified by 
absorbance at 260 nm (Chomczynski and Sacchi 
1987). Total RNA samples were denatured with 
formaldehyde-formamide, electrophoresed in 1% 
agarose gels containing 2.2 M formaldehyde in 1X 
3-N-morpholino-propanesulfonic acid buffer and 
blotted to a nylon membrane (Nylon-1 membrane, 
Gibco BRL, Rockville, MD) by neutral capillary 
transfer. The membrane was baked at 80°C for 
1 h in a vacuum oven and prehybridized in 50% 
formamide hybridization solution and 100 mg/
mL denatured salmon sperm DNA at 42°C for 4 
h. Subsequently, the membrane was probed with a 
32P-labeled rat Mb cDNA (GenBank AF197916; 
online: http://www.ncbi.nlm.nih.gov/ [November 3 
1999]) by random priming (Random Primers DNA 
Labeling System Kit, Gibco BRL) for 16 h at 42°C. 
The membrane was washed under high stringency 
conditions and subjected to autoradiography and 
quantified by phosphorimaging, using ImageJ 
software. All blots were stripped and rehybridized 
with a 32P-labeled RNA probe specific for 18S 
ribosomal RNA (18S c-rRNA), synthesized 
by in vitro transcription (Maxi Script In vitro 
transcription kit, Ambion, Austin, TX), to correct 
for the variability in RNA loading. The results were 
expressed as mean ± s.e.m. of Mb mRNA/18S 
c-rRNA ratio.
Race-Pat (Rapid amplification of cDNA ends-
Poly(A) test). For testing Mb poly(A) tail length 
through RACE-PAT analysis (Sallés et al. 1999), 
3 µg of total RNA was reverse transcribed using 
200 ng of Oligo(dT) anchor and a mix containing: 
4 µl 5X M-MLV Reverse Transcriptase (RT) buffer 
(Invitrogen Life Technologies, Carlsbad, CA, USA), 
2 µl DEPC water, 1 µl of dNTPs mixture (10 mM) 
and 1 µl enzyme M-MLV RT (200U) (Invitrogen 
Life Technologies, Carlsbad, CA, USA), at 42°C 
for 1 h. The samples were, then, incubated at 70°C 
for 15 min to inactivate the RT enzyme. PCR was 
performed for poly(A) tail amplification using 3 µl 
of the reverse transcription reaction product and 22 
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µl of standard PCR reaction containing 25 pmol of 
each primer; anchor primer (5’- GCG AGC TCC 
GCG GCC GCGT – 3’) and Mb sense primer (5’ 
– ATT TGA CCC CAA ATG CAA GT – 3’). The 
PCR conditions were established for a reaction, 
as follows: 1 hold of 5 min at 95°C; 30 cycles: i) 
30 sec at 95°C, ii) 1 min at 60.1°C, iii) 1 min at 72°C; 
then one hold of 10 min at 72°C. Thereafter, the 
PCR products were subjected to electrophoresis 
on 2.5% agarose gel containing ethidium bromide, 
to enable the verification of the amplicon size, 
which was estimated from the bottom to the top 
edge of the smear formed.
Western blot analysis. Soleus, EDL muscles 
and heart were homogenized in Polytron (Polytron 
Aggregate – PT 2100 – Kinematica – Swiss) using 
protein extraction buffer (0.3 M Sucrose; 0.1 M 
KCl; 20 mM Tris-HCl, pH 7.0). The homogenate 
was centrifuged for 40 min at 12,000 g (Eppendorf 
Centrifuge – 5415R – Hamburg - Germany) and 
the protein content of the supernatant (cytosolic 
fraction) was determined by Bradford method 
(Ausubel et al. 1995). Cytosolic protein samples 
(15 µg) were treated with Laemmli sample buffer 
(Laemmli 1970), heated in a boiling water bath 
for 10 min and resolved by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS 
PAGE) using a 4% acrylamide stacking gel and a 
18% acrylamide resolving gel. Electrotransfer of 
proteins from the gel to nitrocellulose membrane 
was performed for 90 min at 300 mA. After 
transfer protein from gel to membrane, nonspecific 
protein binding to the nitrocellulose membrane 
was reduced by preincubating the membrane 2 h 
at room temperature in blocking buffer (1% nonfat 
dry milk, 137 mM NaCl, 2.7 mM KCl, 8 mM 
NaHPO4, 1.4 mM KH2PO4, and 0.02% Tween 20). 
The nitrocellulose membrane was incubated with 
human anti myoglobin antiserum (1/5000; Sigma. 
Modified from Giannocco et al. 2004 and Sertié et 
al. 2014), diluted in blocking buffer overnight at 
4°C and washed for 30 min with the blocking buffer 
without milk. The membranes were, then, incubated 
with secondary antibody in blocking buffer (137 
mM NaCl, 2.7 mM KCl, 8 mM NaHPO4, 1.4 mM 
KH2PO4, and 0.02% Tween 20) for 1 h at room 
temperature and then washed again for 30 min as 
described above (Maniatis et al. 1989). 
The bands were detected by chemiluminescence 
using the home made ECL solution, consisting of 
solution A (1 M Tris - pH 8.5; Pecumaric; Luminol 
and ultra-pure water) and solution B (1 M Tris - 
pH 8.5; hydrogen peroxide 30% and ultra-pure 
water), which were mixed at the time of use. The 
nitrocellulose membranes were Ponceau stained 
for a better analyses of the equal loading of the gels 
(Romero-Calvo et al. 2010, Tang et al. 2011, Vitzel 
et al. 2013, Fortes et al. 2016). Blot densitometry 
was evaluated using Image J Software (National 
Institutes of Health, Bethesda, MD, USA). Results 
were expressed as arbitrary units (AU).
HEMATIMETRIC PARAMETERS
Hematocrit: Capillary tubes were filled with 
samples of heparinized blood, sealed with Bunsen 
burner and placed in a micro centrifuge specific to 
it, at 12,000 g for 7 min. The hematocrit was read 
in a hematocrit reader. 
Red Blood Cell (RBC) count: A sample 
containing 20 µl of heparinized blood was added 
to 4.0 ml of a solution containing sodium citrate 
3.8 g, formaldehyde 2.0 ml distilled water 100.0 ml 
(dilution 1:200). Cells were counted in a Neubauer 
chamber using an optical microscope. The count 
was made at the central reticulum of the chamber, 
and the following calculation was made: Red blood 
cells per mm3 of blood = Hc x 5 x 10 x 200 (where 
5 is the conversion factor for 1 mm2, 10 to 1 mm3 
and 200 is the dilution factor).
Hb concentration: This determination was 
based on the reaction of ferrocyanide (5.0 ml of 
solution with ferrocyanide) with the Hb contained 
in the heparinized blood (20 µl), which was, thus, 
oxidized to methemoglobin. Blood hemoglobin 
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was converted to cyanide Hb by reaction with 
sodium cyanide at pH 7.2. The samples were read 
on a spectrophotometer at 540 nm.
Serum iron levels: Serum iron was assessed 
by a specific dosage kit (Serum Iron LABTEST), 
based on the method of Goodwin (1966), modified. 
Mean corpuscular volume (MCV), mean cor-
puscular Hb (MCH) and mean corpuscular Hb con-
centration (MCHC) calculations: These parameters 
were calculated by using the following formulas: • 
MCV (fentoliter) = hematocrit (%) x 10/red blood 
cells (millions); • HCM (picogram) = Hb (g/dL) x 
10/red blood cells (millions); • MCHC (%) = Hb 
(g/dL) x 100/hematocrit (%) (Failace 2011).
STATISTICAL ANALYSIS OF THE DATA
Kolmorogov-Smirnov test was used to determine the 
normality of the distributions. As the data showed a 
normal distribution, statistical procedures were per-
formed by analysis of variance (ANOVA one way), 
followed by post-test Student-Newman-Keul. When 
only two groups were compared, we used the un-
paired T test. All values were expressed as mean ± 
standard error of the mean (X ± s.e.m.) and signifi-
cance was defined by the values of P <0.05.
RESULTS
LONG-TERM STUDY
As observed in Table I, the animals that received iron 
supplementation or restriction had no significant 
differences in the serum iron concentration, 
hematocrit and MCH compared with the control 
group. However, the number of red blood cell was 
increased in the iron supplementation group (IS 
- 8.838.000 ±206.574) and in the iron restriction 
group (IR - 8.680.000 ±95.917) compared to control 
group (7.524.000 ±322.810). Since hematocrit 
of both treatment groups, IS (53.5% ±0.5) and 
IR (52.4% ±0.6), was not different compared to 
control (49.4% ±2.3), when we calculated MCV 
in IS (60.63 fL ±1.42) and IR (60.38 fL ±0.62) 
presented decreased compared to control (65.72 
fL ±1.67), which means that even presenting a 
higher number of cells in both treatments compared 
to control, in a small hematocrit, this means that 
the volume of the cells are reduced. In addition, 
IR group showed a significant increase in the Hb 
(16.19 g/dL ±0.26) content and MCHC (30.89% 
±0.24) compared to control (14.30 g/dL ± 0.37 Hb, 
29.08% ±0.92 MCHC) and IS (15.15 g/dL ±0.40 
Hb, 28.30% ±0.50 MCHC).
The data of Mb mRNA and protein expression, 
as well as of Mb mRNA poly(A) tail length in soleus, 
EDL and heart muscle are shown in the figures 1, 2 
(a-c) and 2 (d-f) respectively. Figure 1a shows that 
Mb gene expression is increased 1.9 X in IR group 
(1.928 ±0.394) compared to control (1.000 ±0.093) 
and 2.2X compared to IS (0.876 ±0.095) groups. 
Figure 1b presents Mb protein content, and the IR 
group (1.528 ±0.1736) Mb content is increased 
1.5X compared to control (1.000 ±0.057) and 1.4X 
TABLE I 
Effect of iron supplementation or restriction on serum iron concentration and blood cells parameters in rats.
Control Iron Supplementation Iron Restriction
Serum Iron concentration (µg/dL) 138.6 ± 14.3 130.7 ± 15.1 149.4 ± 8.7
Red Blood Cell Number (RBC/mm3) 7.524.000 ± 322.810 8.838.000 ± 206.574* 8.680.000 ± 95.917*
Hematocrit (%) 49.4 ± 2.3 53.5 ± 0.5 52.4 ± 0.6
Hemoglobin (g/dL) 14.30 ± 0.37 15.15 ± 0.40 16.19 ± 0.26**
MCV (fL) 65.72 ± 1.67   60.63 ± 1.42* 60.38 ± 0.62*
MCH (pg) 19.11 ± 0.71 17.16 ± 0.59 18.66 ± 0.32
MCHC (%) 29.08 ± 0.92 28.30 ± 0.50 30.89 ± 0.24#
Data are reported as means ± s.e.m of 3 independent experiments. MCV: mean corpuscular volume; MCH: mean corpuscular 
hemoglobin; MCHC: mean corpuscular hemoglobin concentration. * P <0.05 vs control, # P <0.05 vs supplementation. ** P <0.01 
vs control (One-way ANOVA). The number of animals used per group varied from 5-9.
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compared to IS (1.084 ±0.126) groups. However, 
when we evaluated poly(A) tail in Soleus muscle 
the length of this tail was not altered in IS (1.154 
±0.142) and IR (1.319 ±0.212) groups compared 
to control (1.000 ±0.084). No significant changes 
were observed in all studied parameters in EDL and 
heart muscles in the different treatment conditions 
studied (Figure 2 a-c and Figure 2 d-f, respectively). 
Figure 1 - Iron Restriction increased myoglobin gene and protein expression in Soleus muscle. a – Northern blot analysis of 
Soleus muscle Mb mRNA and 18S ribosomal subunit expression of control, iron-supplemented (30 days) and iron-restricted 
(30 days) rats is shown at the top, and the graphic representation of the ratio of Mb and 18S mRNA blots densitometry in 
shown at the bottom of the figure in arbitrary units (AU); b - Western blot analysis of the Soleus muscle Mb content (at the 
top) and the graphic representation of the blots densitometry (at the bottom); c – At the top, the amplicon sizes are represented 
by the smear formed after PCR; at the bottom, the graphical representation of Mb mRNA poly(A) tail length based on 
of the amplicon sizes estimated from the bottom to the top of the smear formed. Data are reported as means ± s.e.m of 3 
independent experiments (n=15). * P <0.0015 and ** P <0.0001 vs control and supplementation groups. One-way ANOVA.
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Figure 2 - Iron restriction or supplementation do not affect Myoglobin gene and protein expression in Extensor Digitorum 
Longus and Cardiac Muscle. Northern blot analysis of EDL Muscle (a) and Cardiac Muscle (d) Mb mRNA and 18S ribosomal 
subunit expression in control, iron-supplemented (30 days) and iron-restricted (30 days) rats is shown at the top, and the graphic 
representation of the ratio of Mb and 18S mRNA blots densitometry is shown at the bottom of the figure in arbitrary units (AU); 
Western blot analysis of the EDL Muscle (b) and Cardiac Muscle (e) Mb content (at the top) and the graphic representation of the 
blots densitometry (at the bottom); c and f - At the top, the amplicon sizes represented by the smear formed after PCR; at the bottom, 
the graphical representation of Mb mRNA poly(A) tail length based on analysis of the amplicon sizes estimated from the bottom 
to the top of the smear formed in EDL Muscle (c) and Cardiac Muscle (d). Data are reported as means ± s.e.m of 3 independent 
experiments (n=15). P>0.05. One-way ANOVA.
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SHORT-TERM STUDY
As already pointed out, iron restriction did not 
change serum iron concentration (173.2 ±10.76), 
which remained similar to that of the control group 
(172.8 ±24.85). When IR animals were subjected to 
acute iron treatment, a significant increase in serum 
iron was observed, at all times studied: 30’ (289.4 
±50.32); 1h (287.3 ±16.73); 2 h (257.5 ±25.18); 
12h (298.1 ±21.63) compared to control, however 
at 24 h (124.3 ±13.99) serum iron concentration 
presented significantly decreased compared to 
30’, 1 h, 2 h, and 12 h and was similar to control 
and IR groups (Table II). Mb gene and protein 
expression was not significantly altered in the three 
tissues and all times studied (Figures 3 to 5). The 
same occurred with the Mb mRNA poly (A) tail 
length, as shown in Figures 3c to 5c. The left side 
of Figures 3, 4 and 5 presents the results of iron-
restricted compared to control animals before the 
acute iron supplementation. 
Table II 
Serum iron concentration of rats subjected to iron restriction (IR) and iron restriction followed by iron supplementation 
for 30’ (IS30’), 1 (IS1h), 2 (IS2h), 12 (IS12h) and 24 h (IS24h).
Treatment Control IR IS30’ IS1h IS2h IS12h IS24h
Serum Iron concentration 
(µg/dL)
172.8 ±  
24.85
173.2 ±  
10.76
289.4 ±  
50.32*$
287.3 ±  
16.73**$$
257.5 ±  
25.18*$
298.1 ±  
21.63*$$
124.3± 
13.99## ###
Data are reported as means ± s.e.m. of 3 independent experiments * P <0.05,** P <0.01 vs control; $ P <0.05, $$ P <0.01 vs IR (Iron 
Restriction); ## P <0.01 vs IS30’ and IS2h (Iron restriction followed by Iron supplementation for 30’ and 2h); ### P <0.001 vs IS1h 
and IS12h (iron restriction followed by Iron supplementation for 1h and 12h. One-way ANOVA. The number of animals used per 
group varied from 6 to 8.
DISCUSSION AND CONCLUSIONS
Mb plays a central role in muscle cells functions, 
such as storage and transport of oxygen to the 
mitochondria, these processes are dependent on 
the presence of iron in the heme group of this 
protein (Andrews 2000, Hentze and Kühn 1996, 
Niederkofler et al. 2005). Besides these, some 
proteins involved with iron metabolism are regulated 
by very specific mechanisms that are triggered by 
the intracellular level of iron, a trace element that 
leads to alterations in the half-life of the messenger 
RNAs that encode them (Hentze and Kühn 1996). 
Taking into account these considerations, in this 
study we evaluated the repercussions of iron 
supplementation and restriction, as well as iron 
restriction followed by an iron short-term treatment 
(30 min to 24 h) on Mb mRNA content and poly(A) 
tail length and Mb expression in skeletal (Soleus 
and EDL) and cardiac muscle.
Our results showed that iron supplementation 
for 30 days does not affect Mb mRNA and protein 
expression, as well the poly(A) tail length of this 
transcript, data that suggest that Mb does not seem 
to have a role in iron homeostasis. Dallman and 
Schwartz (1965) showed that during iron anemia 
the content of Mb decreases to a very low level, and 
also showed that after oral iron supplementation, 
Mb take longer than other proteins, such as Hb, to 
recover the normal state. 
Studies performed in iron-treated mice showed 
an accumulation of this ion in soleus and EDL 
skeletal muscles, mainly in the ferritin light chain, 
which stocks iron; they also observed an increase 
of oxidative stress and antioxidant enzymes 
activity in these muscles (Reardon and Allen 
2009). Rodriguez et al. (2007) using microarray 
test, in which 47,000 probes were studied, have 
found that a small number of genes is altered in 
skeletal and cardiac muscle after iron overload, 
only those that, in some way, are involved in the 
metabolism of glucose and lipids. Neither study 
identified alterations in Mb gene expression.
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Figure 3 - Acute iron supplementation following iron restriction does not change myoglobin gene and protein expression in Soleus 
muscle. a - Northern blot of Soleus muscle Mb mRNA and 18S ribosomal subunit expression of control, iron restricted (30 days - 
IR), and after restriction rats received by I.p. Injection of iron within 30 min to 24 h (IS30’, IS1h, IS2h, IS12h, IS24h), is shown at 
the top, and the graphic representation of the ration of Mb and 18S mRNA blots densitometry is shown at the bottom of the figure 
in arbitrary units (AU). b - Westhern blot analysis of the Soleus muscle Mb content (at the top) and graphic representation of the 
blots densitometry (at the bottom). c - At the top, the amplicom sizes are represented by the smear formed after PCR; at the bottom, 
the graphical representation of Mb mRNA poly(A) tail length based on of the amplicon sizes estimated from the bottom to the 
top of the smear formed. The left side of a, b and c presents the results of iron-restricted vs control animals before the acute iron 
supplementation. Data are reported as means ± s.e.m of 3 independent experiments (n=10). * P<0.05 and ** P<0.0001 vs control. 
One-way ANOVA.
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Figure 4 - Acute iron supplementation following iron restriction does not change myoglobin gene and protein expression in EDL 
muscle. a - Northern blot of EDL muscle Mb mRNA and 18S ribosomal subunit expression of control, iron restricted (30 days - IR), 
and after restriction rats received by I.p. Injection of iron within 30 min to 24 h (IS30’, IS1h, IS2h, IS12h, IS24h), is shown at the 
top, and the graphic representation of the ration of Mb and 18S mRNA blots densitometry is shown at the bottom of the figure in 
arbitrary units (AU). b - Westhern blot analysis of the EDL muscle Mb content (at the top) and graphic representation of the blots 
densitometry (at the bottom). c - At the top, the amplicom sizes are represented by the smear formed after PCR; at the bottom, 
the graphical representation of Mb mRNA poly(A) tail length based on of the amplicon sizes estimated from the bottom to the 
top of the smear formed. The left side of a, b and c presents the results of iron-restricted vs control animals before the acute iron 
supplementation. Data are reported as means ± s.e.m of 3 independent experiments (n=10). P>0.05. One-way ANOVA.
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Figure 5 - Acute iron supplementation following iron restriction does not change myoglobin gene and protein expression in 
Cardiac muscle. a - Northern blot of cardiac muscle Mb mRNA and 18S ribosomal subunit expression of control, iron restricted 
(30 days - IR), and after restriction rats received by I.p. Injection of iron within 30 min to 24 h (IS30’, IS1h, IS2h, IS12h, IS24h), is 
shown at the top, and the graphic representation of the ration of Mb and 18S mRNA blots densitometry is shown at the bottom of the 
figure in arbitrary units (AU). b - Westhern blot analysis of the cardiac muscle Mb content (at the top) and graphic representation 
of the blots densitometry (at the bottom). c - At the top, the amplicom sizes are represented by the smear formed after PCR; at the 
bottom, the graphical representation of Mb mRNA poly(A) tail length based on of the amplicon sizes estimated from the bottom to 
the top of the smear formed. The left side of a, b and c presents the results of iron-restricted vs control animals before the acute iron 
supplementation. Data are reported as means ± s.e.m of 3 independent experiments (n=10). P>0.05. One-way ANOVA.
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Serum iron and Hb concentrations also remained 
unaltered in iron supplementation condition. It is 
known that under iron loading, hepcidin production 
increases, leading to the reduction of iron export 
into plasma from enterocytes and macrophages, 
and the contrary occurs in iron deprivation states. 
By these mechanisms, this protein regulates 
plasma iron concentration according to the need 
of the body (Knutson 2010, Anderson et al. 2007, 
Ganz and Nemeth 2012), and this could explain 
why serum iron concentration was kept similar to 
the control group levels. Our data on Hb content 
in this condition is also consistent with those of 
Blayney et al. (1976) study, in which no significant 
difference in Hb concentration was observed in rats 
receiving oral iron supplementation. Interestingly, 
the rats subjected to iron supplementation and iron 
restriction showed a significant increase in red 
blood cell quantity, but a reduction of their mean 
corpuscular volume, which could explain why the 
hematocrit remained similar to the control group. 
On the other hand, long-term iron restriction 
(30 days) led to an increase on Mb gene and protein 
expression, and this effect was tissue-specific, since 
it was restricted to the soleus muscle. In parallel, 
there was an increase in the Hb concentration, 
as compared to control, showing that the 30-day 
treatment with tannic acid may lead to an increase 
in protein, prior to installing an anemia that would 
take longer to occur with such treatment (Afsana et 
al. 2004). This might suggest that when the supply 
of iron is reduced, responses are triggered leading 
to increased synthesis of this protein, which could 
represent a mechanism to facilitate the storage of 
iron in an attempt to keep their essential functions 
for O2 transport through the tissues. The use of 
tannic acid as iron chelator is due its capacity 
to decrease iron bioavailability to the organism 
forming a tannin-iron complex (Disler et al. 1975, 
Andrews et al. 2014, Jamarillo et al. 2015, Oh et 
al. 2015). Just as occurred with the soleus muscle, 
which had an increase of Mb expression in the iron-
restricted rat. The HIF alpha 1 mRNA expression in 
the iron-restricted group was shown to be decreased, 
however, the difference failed to reach statistical 
significance (data not shown). Thus, it seems that in 
this situation the supply of O2 to the tissues is being 
maintained within the normal range. It is known 
that HIF 1 alpha is upregulated by hypoxia and 
by iron chelators. Thus, reduced iron availability 
could be one factor that, by enhancing HIF alpha, 
could lead to the increase in the Mb content in 
iron-restricted groups. Also, regarding hematology 
evaluation conducted on the long-term study, it 
was found that the observed increase in the number 
of red blood cells in the treated groups, although 
significant, does not represent abnormality. These 
results are in accordance with the data observed by 
Akase et al. (2004) and Cerven et al. (2008), that is, 
in our data (number of red blood cells, hematocrit, 
hemoglobin, MCV, MCH and MCHC) have values 
that are between the reference data, concerning the 
animals that received no treatment, and are within 
a reference range considered normal. That is, the 
significant increase in red blood cells observed in 
the groups submitted to the treatments described, 
without increasing of the hematocrit, indicates that 
the mean corpuscular volume of them is less than 
the control group, but this information does not 
indicate that these cells are microcytic.
The iron supplementation for short periods 
of time after rats have been iron-restricted for 30 
days did not promote any alteration in the poly(A) 
tail length nor in the Mb mRNA content. This data 
further support the point we have raised, that Mb 
does not seem to have a role in iron homeostasis 
when iron is in abundance. This seems not to be true 
in iron restricted-conditions, when rapid responses 
were elicited on Hb, as well as on Mb expression. 
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